MIFLONIDE BRIZZ 400 MCG CAP DURA INAL OR CT BL AL PLAS PVC/PVDC TRANS X 60 + INAL
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1006811700067 -
GGREM
526520110096407 -
Código de barras
7896261020573
O que a fonte publica
- Detentor do registro
- NOVARTIS BIOCIENCIAS S.A
- Princípios ativos
- BUDESONIDA
- Embalagem
- 400 MCG CAP DURA INAL OR CT BL AL PLAS PVC/PVDC TRANS X 60 + INAL
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- R3D1 - ANTIASMÁTICOS/DPOC CORTICOSTERÓIDES INALANTES
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- MIFLONIDE BRIZZ 400 MCG CAP DURA INAL OR CT BL AL PLAS PVC/PVDC TRANS X 60 + INAL
- MIFLONIDE BRIZZ
- BUDESONIDA
Dados completos da fonte
{
"name": "MIFLONIDE BRIZZ 400 MCG CAP DURA INAL OR CT BL AL PLAS PVC/PVDC TRANS X 60 + INAL",
"holder": "NOVARTIS BIOCIENCIAS S.A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896261020573"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526520110096407",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "56.994.502/0001-30",
"priceRegime": "Regulado",
"productName": "MIFLONIDE BRIZZ",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "400 MCG CAP DURA INAL OR CT BL AL PLAS PVC/PVDC TRANS X 60 + INAL",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "62.38",
"icms-12": "70.89",
"icms-17": "75.16",
"icms-18": "76.07",
"icms-19": "77.01",
"icms-20": "77.98",
"icms-21": "78.96",
"icms-22": "79.97",
"icms-23": "81.01",
"icms-17.5": "75.61",
"icms-19.5": "77.49",
"icms-20.5": "78.47",
"icms-22.5": "80.49",
"icms-12-alc": "70.04",
"icms-17-alc": "74.25",
"icms-18-alc": "75.16",
"icms-19-alc": "76.09",
"icms-20-alc": "77.04",
"icms-21-alc": "78.01",
"icms-22-alc": "79.01",
"icms-23-alc": "80.04",
"withoutTaxes": "61.63",
"icms-17.5-alc": "74.70",
"icms-19.5-alc": "76.56",
"icms-20.5-alc": "77.52",
"icms-22.5-alc": "79.52"
},
"pisCofinsList": "Positiva",
"substanceText": "BUDESONIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "85.98",
"icms-12": "97.71",
"icms-17": "103.60",
"icms-18": "104.85",
"icms-19": "106.15",
"icms-20": "107.49",
"icms-21": "108.84",
"icms-22": "110.23",
"icms-23": "111.66",
"icms-17.5": "104.22",
"icms-19.5": "106.81",
"icms-20.5": "108.16",
"icms-22.5": "110.95",
"icms-12-alc": "96.83",
"icms-17-alc": "102.65",
"icms-18-alc": "103.90",
"icms-19-alc": "105.19",
"icms-20-alc": "106.50",
"icms-21-alc": "107.84",
"icms-22-alc": "109.23",
"icms-23-alc": "110.65",
"withoutTaxes": "85.20",
"icms-17.5-alc": "103.27",
"icms-19.5-alc": "105.84",
"icms-20.5-alc": "107.17",
"icms-22.5-alc": "109.93"
},
"invalidBarcodes": [],
"activeSubstances": [
"BUDESONIDA"
],
"therapeuticClass": "R3D1 - ANTIASMÁTICOS/DPOC CORTICOSTERÓIDES INALANTES",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1006811700067",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "R3D1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526520110096407"